08232017Headline:

Lansing, Michigan

HomeMichiganLansing

Email David Mittleman David Mittleman on LinkedIn David Mittleman on Facebook David Mittleman on Avvo
David Mittleman
David Mittleman
Attorney • (888) 227-4770

Trasylol Injection During Heart Surgery Leads to Dialysis

Comments Off

In 2006, concerns about Trasylol linked the drug to higher rates of heart attach, stroke, kidney failure and death. Some experts have estimated that it may have caused as many as 1,000 deaths a month while it was on the market.

On November 5, 2007, the Food and Drug Administration (FDA) announced that Bayer Pharmaceuticals agreed to an FDA-requested suspension of Trasylol, a drug used to control bleeding during heart surgery. In May 2008, a Trasylol recall was announced after a study published in the New England Journal of Medicine.

Were the FDA and Bayer slow to act on Trasylol injuries and deaths? A lawsuit recently filed on behalf of two heart surgery patients seeks damages for renal failure requiring dialysis caused by injections of Trasylol. The patients were injected with Trasylol prior to their respective operations.

The first sign of a problem is kidney failure. Dialysis helps provide the function of normal kidneys by removing waste products from the blood and helps remove excess fluid from the body. It is an expensive and time-consuming process, and it does not cure the underlying problem.

If you or a loved one have been injured by Trasylol, you have legal rights. Contact us to see if we can help.